Expression and clinical significance of aminopeptidase N/CD13 in non-small cell lung cancer

Journal of Cancer Research and Therapeutics

Volumn 11, Issue 1, 2015, Pages 223-228

  Zhang, Quan ^a   Wang, Jinghui ^a   Zhang, Haiqing ^a   Zhao, Dan ^a   Zhang, Zongde ^a   Zhang, Shucai ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Aminopeptidase N CD13; immunohistochemistry; non small cell lung cancer; prognosis

Indexed keywords

MICROSOMAL AMINOPEPTIDASE;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CELL MEMBRANE; CLINICAL FEATURE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PARENCHYMA CELL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; AGED; CARCINOMA, NON-SMALL-CELL LUNG; GENE EXPRESSION; GENETICS; LUNG NEOPLASMS; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; RISK FACTOR; SURVIVAL;

ADULT; AGED; ANTIGENS, CD13; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; FEMALE; GENE EXPRESSION; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 84928616673     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.138007     Document Type: Article

References (26)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
2. Non-Small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group. BMJ 1995;311:899-909.
3. Antczak C, De Meester I, Bauvois B. Ectopeptidases in pathophysiology. Bioessays 2001;23:251-60.
4. Look AT, Ashmun RA, Shapiro LH, Peiper SC. Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N. J Clin Invest 1989;83:1299-307.
5. Ashmun RA, Look AT. Metalloprotease activity of CD13/aminopeptidase N on the surface of human myeloid cells. Blood 1990;75:462-9.
6. Riemann D, Kehlen A, Langner J. CD13 - Not just a marker in leukemia typing. Immunol Today 1999;20:83-8.
7. Alliot F, Rutin J, Leenen PJ, Pessac B. Pericytes and periendothelial cells of brain parenchyma vessels co-express aminopeptidase N, aminopeptidase A, and nestin. J Neurosci Res 1999;58:367-78.
8. Tokuhara T, Hattori N, Ishida H, Hirai T, Higashiyama M, Kodama K, et al. Clinical significance of aminopeptidase N in non-small cell lung cancer. Clin Cancer Res 2006;12:3971-8.
9. Ikeda N, Nakajima Y, Tokuhara T, Hattori N, Sho M, Kanehiro H, et al. Clinical significance of aminopeptidase N/CD13 expression in human pancreatic carcinoma. Clin Cancer Res 2003;9:1503-8.
10. Hashida H, Takabayashi A, Kanai M, Adachi M, Kondo K, Kohno N, et al. Aminopeptidase N is involved in cell motility and angiogenesis: Its clinical significance in human colon cancer. Gastroenterology 2002;122:376-86.
11. Surowiak P, Drag M, Materna V, Suchocki S, Grzywa R, Spaczyñski M, et al. Expression of aminopeptidase N/CD13 in human ovarian cancers. Int J Gynecol Cancer 2006;16:1783-8.
12. van Hensbergen Y, Broxterman HJ, Rana S, van Diest PJ, Duyndam MC, Hoekman K, et al. Reduced growth, increased vascular area, and reduced response to cisplatin in CD13-overexpressing human ovarian cancer xenografts. Clin Cancer Res 2004;10:1180-91.
13. Yamashita M, Kajiyama H, Terauchi M, Shibata K, Ino K, Nawa A, et al. Involvement of aminopeptidase N in enhanced chemosensitivity to paclitaxel in ovarian carcinoma in vitro and in vivo. Int J Cancer 2007;120:2243-50.
14. Zhang S, Li Q, Zhang Q, Wang J, Zhang H, Zhang Z, et al. Expression of ERCC1 and class III ß-tubulin in resected non-small cell lung cancer and its correlation with platinum-based adjuvant chemotherapy. Int J Biol Markers 2010;25:141-9.
15. Curnis F, Cattaneo A, Longhi R, Sacchi A, Gasparri AM, Pastorino F, et al. Critical role of flanking residues in NGR-to-isoDGR transition and CD13/integrin receptor switching. J Biol Chem 2010;285:9114-23.
16. Ito S, Miyahara R, Takahashi R, Nagai S, Takenaka K, Wada H, et al. Stromal aminopeptidase N expression: Correlation with angiogenesis in non-small-cell lung cancer. Gen Thorac Cardiovasc Surg 2009;57:591-8.
17. Wickström M, Larsson R, Nygren P, Gullbo J. Aminopeptidase N (CD13) as a target for cancer chemotherapy. Cancer Sci 2011;102:501-8.
18. Grujiæ M, Renko M. Aminopeptidase inhibitors bestatin and actinonin inhibit cell proliferation of myeloma cells predominantly by intracellular interactions. Cancer Lett 2002;182:113-9.
19. Amãlinei C, Cãruntu ID, Bãlan RA. Biology of metalloproteinases. Rom J Morphol Embryol 2007;48:323-34.
20. Tokuhara T, Adachi M, Hashida H, Ishida H, Taki T, Higashiyama M, et al. Neutral endopeptidase/CD10 and aminopeptidase N/CD13 gene expression as a prognostic factor in non-small cell lung cancer. Jpn J Thorac Cardiovasc Surg 2001;49:489-96.
21. Ichimura E, Yamada M, Nishikawa K, Abe F, Nakajima T. Immunohistochemical expression of aminopeptidase N (CD13) in human lung squamous cell carcinomas, with special reference to bestatin adjuvant therapy. Pathol Int 2006;56:296-300.
22. Chambers AF, Matrisian LM. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 1997;89:1260-70.
23. Saiki I, Fujii H, Yoneda J, Abe F, Nakajima M, Tsuruo T, et al. Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. Int J Cancer 1993;54:137-43.
24. Chang YW, Chen SC, Cheng EC, Ko YP, Lin YC, Kao YR, et al. CD13 (aminopeptidase N) can associate with tumor-associated antigen L6 and enhance the motility of human lung cancer cells. Int J Cancer 2005;116:243-52.
25. Ichinose Y, Genka K, Koike T, Kato H, Watanabe Y, Mori T, et al. Randomized double-blind placebo-controlled trial of bestatin in patients with resected stage I squamous-cell lung carcinoma. J Natl Cancer Inst 2003;95:605-10.
26. Furuse K, Fukuoka M, Genka K, Kato H, Tsubura E, Ohta M, et al. Double blind controlled study of ubenimex (Bestatin) against squamous cell lung cancer - A multicenter cooperative study. Gan To Kagaku Ryoho 1993;20:1187-94.